Shares in Novo Nordisk fell as much as 30% after it slashed sales and profits forecasts for the second time this year amid pressure from rival Eli Lilly.Read More

You might also be interested in reading Maker, Now Rebranded to Sky, Draws Ire From DeFi Community on Controversial Stablecoin Change.